Mitchell Capital Management CO Abbott Laboratories Transaction History

Mitchell Capital Management CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 08, 2024	SELL	$100.73 - $112.44 $43,313 - $48,349	-430 Reduced 1.78%	23,667 $2.46 Million
Q1 2024 May 06, 2024	BUY	$109.52 - $120.96 $88,163 - $97,372	805 Added 3.46%	24,097 $2.74 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $612,209 - $749,395	-6,788 Reduced 22.57%	23,292 $2.56 Million
Q3 2023 Nov 03, 2023	SELL	$95.53 - $114.62 $374,573 - $449,425	-3,921 Reduced 11.53%	30,080 $2.91 Million
Q2 2023 Aug 08, 2023	SELL	$100.78 - $112.29 $17,636 - $19,650	-175 Reduced 0.51%	34,001 $3.71 Million
Q1 2023 May 08, 2023	BUY	$96.86 - $114.01 $1.84 Million - $2.17 Million	19,003 Added 125.24%	34,176 $3.46 Million
Q4 2022 Feb 13, 2023	SELL	$95.06 - $111.52 $426,914 - $500,836	-4,491 Reduced 22.84%	15,173 $1.67 Million
Q3 2022 Oct 28, 2022	SELL	$96.76 - $112.03 $319,114 - $369,474	-3,298 Reduced 14.36%	19,664 $1.9 Million
Q2 2022 Jul 29, 2022	BUY	$102.07 - $123.37 $45,523 - $55,023	446 Added 1.98%	22,962 $2.5 Million
Q1 2022 Apr 29, 2022	BUY	$114.02 - $139.04 $2.57 Million - $3.13 Million	22,516 New	22,516 $2.67 Million

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $208B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Mitchell Capital Management CO, based on Form 13F filings with the SEC.

Stay updated on Mitchell Capital Management CO with notifications on news.